These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 18556979)
1. Tear flow study in renal transplant patients receiving cyclosporine A. Jain AK; Sukhija J; Sakhuja V; Kohli HS; Sud K Ann Ophthalmol (Skokie); 2008; 40(1):31-4. PubMed ID: 18556979 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal tear study after cyclosporine in kidney transplant recipients. Palmer SL; Bowen PA; Green K Ophthalmology; 1996 Apr; 103(4):670-3. PubMed ID: 8618769 [TBL] [Abstract][Full Text] [Related]
3. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF; Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398 [TBL] [Abstract][Full Text] [Related]
4. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral. Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205 [TBL] [Abstract][Full Text] [Related]
5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
6. Lipid profile in post renal transplant patients treated with cyclosporine in Sudan. Suleiman B; El Imam M; Elsabigh M; Eltahir K; Eltahir A; Miskeen E Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):312-7. PubMed ID: 19237829 [TBL] [Abstract][Full Text] [Related]
7. Sequential changes in plasma selenium concentration after cadaveric renal transplantation. Morris-Stiff GJ; Oleesky DA; Smith SC; Jurewicz WA Br J Surg; 2004 Mar; 91(3):339-43. PubMed ID: 14991636 [TBL] [Abstract][Full Text] [Related]
15. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients. Ahmadi F; Naseri R; Lessan-Pezeshki M Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470 [TBL] [Abstract][Full Text] [Related]
16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy. El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298 [TBL] [Abstract][Full Text] [Related]
18. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF; Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978 [TBL] [Abstract][Full Text] [Related]
19. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948 [TBL] [Abstract][Full Text] [Related]